Oprah's Weight Loss Dilemma: The Ozempic cover art

Oprah's Weight Loss Dilemma: The Ozempic

Oprah's Weight Loss Dilemma: The Ozempic

By: Quiet. Please
Listen for free

About this listen

 Join us on "The Oprah Ozempic Odyssey," where we explore the intriguing world of weight loss through the lens of Oprah Winfrey's recent remarks about the weight loss drug, Ozempic. Dive into the heated debate surrounding the use of weight loss drugs, and discover the pros and cons of Ozempic as we break down its potential benefits and side effects. Through thoughtful discussions and a touch of humor, we help you navigate this complex topic, providing insights and considerations to make informed decisions on your own weight loss journey. Join us as we dissect the stigma associated with weight loss drugs and empower you to take control of your path to a healthier you. Whether you're Team Oprah or Team Treadmill, "The Oprah Ozempic Odyssey" guides you toward a balanced perspective on the road to a healthier lifestyle.2023 Quiet. Please Hygiene & Healthy Living Physical Illness & Disease Politics & Government
Episodes
  • Ozempic Weight Loss Breakthrough: New Study Reveals Muscle Changes, Celebrity Insights, and Future of Diet Medications

    Ozempic Weight Loss Breakthrough: New Study Reveals Muscle Changes, Celebrity Insights, and Future of Diet Medications
    Aug 9 2025
    Ozempic, a medication originally designed to treat type two diabetes, remains at the center of public fascination and debate due to its widespread use for weight loss. In just the last week, new research and celebrity commentary have deepened the conversation about both the benefits and potential drawbacks of this so-called game-changing drug. A study published by University of Utah Health early this week explored how Ozempic-induced weight loss affects a person’s body composition. According to the study, while individuals can lose a significant portion of their overall weight on Ozempic, the reduction in muscle mass may not be as severe as previously thought. Most of the decrease in lean mass in test subjects was traced to non-muscle tissues, particularly the liver, which actually shrank by about half its original size in the animal model. The loss of liver mass may be a healthy component of weight loss, potentially reducing the risk of conditions like fatty liver disease. However, the researchers also observed that some skeletal muscles experienced as much as a six percent decrease in size and, most notably, these muscles could become weaker even if their actual volume did not change much. This raises pressing questions about how using Ozempic for significant weight loss could impact strength and mobility. The senior author of the study, Katsu Funai, highlighted the urgent need for robust human-based research to clarify the actual risk and benefit profile of Ozempic among real-world users, especially as its popularity continues to spread.

    Media coverage over the past few days has turned a spotlight on “Ozempic feet,” a term being used to describe visible changes to the feet resulting from rapid weight loss on the medication. According to experts quoted in a recent AOL report, several celebrities, including Oprah Winfrey and Sharon Osbourne, have reportedly experienced such side effects. As fat and even some muscle mass are shed, the skin on the feet can become saggy and wrinkled and the fit of shoes is often altered, sometimes leading to pain or discomfort. Though some of these changes are a natural consequence of losing substantial weight, experts caution that adjustments, including choosing new footwear or orthotic inserts, may be necessary for comfort and stability.

    The conversation took a more personal and reflective turn this week as Oprah Winfrey publicly discussed her own history with weight loss and the use of Ozempic. During a live WeightWatchers event, Oprah issued a heartfelt apology for having sparked unhealthy diet culture over the years through her previous messaging on her talk show and in her magazines. This apology comes after she acknowledged earlier this year that she herself lost forty pounds using a weight-loss medication understood to be Ozempic, despite having previously referred to the use of such drugs as “the easy way out.” Her frank disclosure adds a human dimension to the ongoing debate, underscoring the complexity of weight, self-image, and the tools available for managing health.

    Despite the buzz, it is important for listeners to know that not all effects of Ozempic are positive or enduring. Semaglutide, the main ingredient in Ozempic, has been linked in recent studies to significant muscle loss, particularly in women and older adults. Research published this week warns that when people stop taking Ozempic or similar GLP-1 receptor agonist drugs, they frequently experience a rebound effect, regaining a substantial portion of the weight lost during treatment. The extent of this weight regain varies but tends to occur consistently within weeks of discontinuation. Experts say that the magnitude of this rebound likely depends on the drug and the user’s commitment to lifestyle changes during and after medication.

    As pharmaceutical companies race to develop new and potentially better alternatives, Eli Lilly recently unveiled that its oral weight-loss drug, orforglipron, could achieve double-digit percent reductions in body weight and offer a pill-based alternative to injectables like Ozempic. However, as with all medications, these advancements will need rigorous study to understand their long-term impact on health, including muscle and organ integrity.

    Thanks for listening, please subscribe, and remember—this episode was brought to you by Quiet Please podcast networks. For more content like this, please go to Quiet Please dot Ai. Be sure to come back next week for more.

    Some great Deals https://amzn.to/49SJ3Qs

    For more check out http://www.quietplease.ai
    Show More Show Less
    4 mins
  • Ozempic Breakthrough: Weight Loss Drug Shows Promising Brain Protection and Cultural Impact in Medical Transformation

    Ozempic Breakthrough: Weight Loss Drug Shows Promising Brain Protection and Cultural Impact in Medical Transformation
    Aug 6 2025
    Ozempic, a medication initially approved for managing type two diabetes, continues to be at the forefront of conversations about medical weight loss, especially given the significant news and research developments of the past week. The drug, which contains the active ingredient semaglutide, works by mimicking a hormone called glucagon-like peptide one and has shown effectiveness for weight management by helping to regulate blood sugar and suppress appetite. According to a recent report from Science Daily, three new studies presented at a major neurology meeting this week reveal that Ozempic may also have substantial brain-protective effects, notably reducing deaths from stroke and enhancing patient recovery. In one of these studies, researchers found that stroke patients using Ozempic had markedly lower mortality rates—5 percent for Ozempic users versus over 21 percent for nonusers. The findings have led medical experts to suggest that Ozempic could eventually have a broader role in preventing and mitigating the long-term consequences of stroke, illustrating how the drug’s benefits may stretch beyond weight and diabetes management.

    However, the newfound prominence of Ozempic has also led to more critical scrutiny regarding its safety and long-term effects. A study highlighted by ABC News and KGUN9 in the last week warns that while GLP one agonists like Ozempic help to lower weight and may even protect the heart, they might also contribute to loss of lean muscle mass. Muscle is essential for overall health, physical function, and longevity, so losing it could theoretically raise the risk of heart issues and even early death. Experts are urging patients who use Ozempic or similar drugs to combine them with regular exercise and a protein-rich diet to help counteract muscle loss. Additionally, there is growing legal scrutiny over whether Ozempic’s manufacturer gave adequate warnings about the risk of side effects such as gastroparesis, a condition where the stomach slows down digestion too much. Lawsuits are now in progress, focusing on claims that patients were not properly informed about these potential risks. As the popularity and demand for Ozempic increase, some users and doctors are also turning their attention to unregulated GLP one branded supplements, but experts at the Harvard Chan School of Public Health emphasize these supplements do not offer the same clinical benefits and can be potentially unsafe due to a lack of oversight.

    On the cultural front, Oprah Winfrey’s recent candid discussions about her own experience using weight loss medications have made waves this week. In an interview and via social media posts, Winfrey directly addressed the stigma and shame associated with both obesity and the use of medications like Ozempic and Wegovy. She shared her personal struggle with the idea that taking medication is “the easy way out,” but explained that after coming to terms with the scientific evidence supporting these drugs, she is now "absolutely done with the shaming." Oprah emphasized that these medications have given her a sense of control over weight in a way that was never previously possible, and she advocated for shifting public conversations from blame and guilt to compassion and science. However, she also publicly apologized for her role in perpetuating harmful diet culture, acknowledging the need to move away from cycles of restriction and self-judgment. Instead, Winfrey encouraged listeners to approach weight and wellness as multifaceted issues that require medical, psychological, and social understanding.

    Ozempic’s fast-evolving story, with its promise for weight management, potential for new medical benefits, concerns over side effects, and rising influence in wider cultural discussions, signals that the dialogue around weight loss is changing rapidly. The drug is being tested for other health conditions, including cardiovascular disease and even as a potential aid for people with alcohol use disorder or Alzheimer’s, pointing to its wide-ranging medical implications. As new data and testimonials like Oprah’s reach the public, experts, and patients alike are becoming more aware of both the promise and the complexity of using Ozempic for long-term health.

    Thanks for listening, please subscribe, and remember—this episode was brought to you by Quiet Please podcast networks. For more content like this, please go to Quiet Please dot Ai. Come back next week for more.

    Some great Deals https://amzn.to/49SJ3Qs

    For more check out http://www.quietplease.ai
    Show More Show Less
    4 mins
  • Ozempic Weight Loss Breakthrough: Medical Experts Reveal Crucial Health Insights and Potential Risks in 2025

    Ozempic Weight Loss Breakthrough: Medical Experts Reveal Crucial Health Insights and Potential Risks in 2025
    Aug 2 2025
    Ozempic continues to transform conversations about weight loss as public interest remains high and new medical studies prompt deeper questions about its broader impact on health. Over just the last week, a major research update from the University of Virginia has highlighted that while Ozempic and similar drugs are remarkably effective at helping users shed excess weight, they do not consistently improve cardiorespiratory fitness, which is a crucial indicator for long-term health and mortality risk. The research team, led by Dr. Zhenqi Liu, emphasized patient stories describing loss of muscle mass alongside fat reduction. Liu warns that lean muscle is fundamental for posture, mobility, and overall metabolic health, and its depletion from these therapies may increase vulnerability to cardiovascular disease and even lower lifespan. Although the weight loss itself can lead to improvements in blood sugar control and short-term heart and kidney health, the review cautions that additional interventions, such as exercise programs or nutritional supplements, may be needed to ensure the benefits extend to long-term survival and quality of life. The panel ultimately called for larger, more rigorous studies focused on the effects of these drugs on measures such as VO two max, the gold standard for cardiorespiratory fitness, noting that current evidence shows the fitness benefit seen with exercise is not always reproduced with Ozempic alone. This brings urgency to the discussion among health professionals about how to advise patients starting these medications so that healthy weight loss does not come at the expense of strength and resiliency, especially for those who may be at risk for malnutrition or already have low baseline muscle mass.Meanwhile, high-profile figures continue to shape the public narrative. Oprah Winfrey's candid approach has kept her in the headlines, particularly after she recently reaffirmed that she used a medication in the same class as Ozempic, semaglutide, sparking another round of media coverage and online discussion. Earlier this week, Oprah explained on various platforms that while medicine helped curb her hunger, the deeper work was about building new habits, nourishing self-worth, and consistently taking care of her body through routine and mindful choices. She stressed that lasting transformation did not come from the injection alone but required a holistic focus on lifestyle, including mindful eating windows and regular activity. In recent interviews and social media snippets, Oprah has directly addressed both the supporters and critics of pharmaceutical-based weight loss, stating that reaching her healthiest self at seventy required relentless self-compassion combined with science-driven support. This public dialogue has resonated with many who have struggled with weight and is driving a nationwide reflection on the practical and emotional aspects of these new options.The U S Food and Drug Administration has simultaneously sounded the alarm on a growing problem: counterfeit and unapproved versions of these drugs proliferating online. In newly released statements, officials warned consumers to rely on licensed pharmacies, as knockoffs sold by rogue sites have been found to contain incorrect dosages or harmful ingredients, sometimes carrying no active medicine at all. With more than five hundred adverse event reports linked to unapproved versions as of the end of July, the agency urges anyone pursuing these medications to consult physicians and exercise caution rather than seeking quick fixes on the Web.Amidst this dynamic landscape, a trending topic across online forums and video discussions this week is the so-called "Ozempic feet," referring to sagging skin on the soles of those who lose rapid weight. Though dermatologists stress this is not a medical term, it reflects the very real phenomenon of loose skin and tissue changes as fat quickly melts away from the body, underscoring the need for holistic care beyond the prescription itself.For listeners seeking the truth about Ozempic in 2025, the consensus from medical experts is that while the medication marks a breakthrough for many living with obesity or type two diabetes, it is not a standalone solution for comprehensive wellness. Sustained, meaningful health still requires regular movement, focused nutrition, and informed medical oversight—a message central to Oprah’s current advocacy as well. And as she recently reminded her audience, you are not a number on a scale. You are a living, breathing miracle. But you have to show up for yourself.Thanks for listening, please subscribe, and remember—this episode was brought to you by Quiet Please podcast networks. For more content like this, please go to Quiet Please dot Ai. Come back next week for more.Some great Deals https://amzn.to/49SJ3QsFor more check out http://www.quietplease.ai
    Show More Show Less
    5 mins
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.